Search
for
Sort by
Research 31–60 of 1000+
- Getting under the skin of hair aging: the impact of the hair follicle environment
- The human skin as a hormone target and an endocrine gland
- Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- The gut‐microbiota‐brain axis: Focus on gut steroids
- Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
- Exploring Hirsutism: Epidemiology, Associated Endocrinal Abnormalities, and Societal Challenges in GCC—A Narrative Review
- Frontal Fibrosing Alopecia and Reproductive Health: Assessing the Role of Sex Hormones in Disease Development
- The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Corticotropin-releasing hormone: An autocrine hormone that promotes lipogenesis in human sebocytes
- The Role of Heat Shock Proteins in the Pathogenesis of Polycystic Ovarian Syndrome: A Review of the Literature
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Sebum Production
- Polycystic ovary syndrome
- Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?
- A Randomized Trial of Oral DHEA Treatment for Sexual Function, Well-Being, and Menopausal Symptoms in Postmenopausal Women with Low Libido
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms
- Prescribing testosterone and DHEA: The role of androgens in women
- Dehydroepiandrosterone (DHEA) and Testosterone Concentrations in Human Hair after Chronic DHEA Supplementation
- Methodology and Challenges to Recruitment to a Randomized, Double-Blind, Placebo-Controlled Trial of Oral DHEA in Postmenopausal Women
- Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate (DHEA-S) in the majority of the alopecia areata patients: Is it a primitive and pathogenic perturbation of hypothalamic-pituitary-adrenal axis?
- Gut–ovary axis and multiomic insights into PCOS in a DHEA-induced rat model
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome